Treatment for HIV-Positive Patients with Fever and Bacterial Infection
Initial Management Approach
- An HIV-positive patient with fever and bacterial infection who has run out of antivirals should immediately receive empiric antibiotic therapy with a beta-lactam plus a macrolide, while urgent efforts are made to restart antiretroviral therapy, as recommended by the Centers for Disease Control and Prevention (CDC) 1
- Assess disease severity and oxygenation status to determine if outpatient or inpatient management is appropriate, according to the CDC 1
- Collect specimens for microbiologic studies before initiating antibiotics, but do not delay antibiotic therapy while waiting for results, as advised by the CDC 1
Antibiotic Selection
- Administer an oral beta-lactam plus an oral macrolide for outpatient treatment, with preferred beta-lactams being high-dose amoxicillin or amoxicillin-clavulanate, and preferred macrolides being azithromycin or clarithromycin, as recommended by the CDC 1
- For inpatient treatment, administer an IV beta-lactam plus a macrolide, with preferred beta-lactams being ceftriaxone, cefotaxime, or ampicillin-sulbactam, according to the CDC 1
- For severe illness requiring ICU, administer an IV beta-lactam plus either IV azithromycin or an IV respiratory fluoroquinolone, as recommended by the CDC 1
Important Considerations
- Never use macrolide monotherapy due to increased risk of drug-resistant Streptococcus pneumoniae in HIV-infected patients, as warned by the CDC 1
- Use fluoroquinolones with caution when tuberculosis is suspected, as they may mask TB symptoms and delay diagnosis, according to the CDC 1
- For patients with Salmonella gastroenteritis, consider ciprofloxacin (750 mg twice daily for 14 days) to prevent extraintestinal spread, as recommended by the CDC 2
- HIV-infected patients with Salmonella septicemia require long-term therapy to prevent recurrence, usually with a fluoroquinolone for susceptible organisms, as advised by the CDC 2
Prophylaxis Considerations
- Initiate or restart TMP-SMZ for PCP prophylaxis if CD4 count is <200 cells/mm³ or unknown, as recommended by the CDC 3
- TMP-SMZ prophylaxis may also help prevent bacterial respiratory infections, according to the CDC 1
- Consider pneumococcal vaccination if not administered within the past 5 years, as recommended by the CDC 3
Follow-up
- Ensure prompt reengagement with HIV care and resumption of antiretroviral therapy, as recommended by the CDC 4
- Test bacterial isolates for antimicrobial susceptibility, particularly for S. pneumoniae and H. influenzae, as advised by the CDC 5
- Adjust antibiotic therapy based on culture results and clinical response, according to the CDC 1